Provisional assignment of new diseases of uncertain etiology or emergency use (U00-U49)

U07Emergency use of U07

U07.0Vaping-related disorder
› Dabbing related lung damage
› Dabbing related lung injury
› E-cigarette, or vaping, product use associated lung injury [EVALI]
› Electronic cigarette related lung damage
› Electronic cigarette related lung injury
Use Additional Code: code to identify manifestations, such as:
› abdominal pain (R10.84)
› acute respiratory distress syndrome (J80)
› diarrhea (R19.7)
› drug-induced interstitial lung disorder (J70.4)
› lipoid pneumonia (J69.1)
› weight loss (R63.4)

U07.1COVID-19
Use Additional Code: code to identify pneumonia or other manifestations, such as:
› pneumonia due to COVID-19 (J12.82)
Use Additional Code: code, if applicable, for associated conditions such as:
› COVID-19 associated coagulopathy (D68.8)
› disseminated intravascular coagulation (D65)
› hypercoagulable states (D68.69)
› thrombophilia (D68.69)
Excludes 2: coronavirus as the cause of diseases classified elsewhere (B97.2-)
› pneumonia due to SARS-associated coronavirus (J12.81)

U09Post COVID-19 condition

U09.9Post COVID-19 condition, unspecified
› Post-acute sequela of COVID-19
Code First: the specific condition related to COVID-19 if known, such as:
› chronic respiratory failure (J96.1-)
› loss of smell (R43.8)
› loss of taste (R43.8)
› multisystem inflammatory syndrome (M35.81)
› pulmonary embolism (I26.-)
› pulmonary fibrosis (J84.10)

This code enables establishment of a link with COVID-19.
This code is not to be used in cases that are still presenting with active COVID-19. However, an exception is made in cases of re-infection with COVID-19, occurring with a condition related to prior COVID-19.